Pomalidomide (Pomalyst)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pomalidomide (Pomalyst), covering 2025-04-11 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma [Phase 1]